Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06437678
What this trial is testing

Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer

Who this might be right for
Gastric Cancer
Zhejiang Cancer Hospital 50
Early research (Phase 1)UnknownNCT02211443
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sinocelltech Ltd. 21
Early research (Phase 1)UnknownNCT01239485
What this trial is testing

Study of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and Adolescents

Who this might be right for
Acute Leukemia
Seoul National University Hospital 18
Early research (Phase 1)Study completedNCT00005638
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01139138
What this trial is testing

Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumors+1 more
The Queen Elizabeth Hospital 49
Testing effectiveness (Phase 2)WithdrawnNCT00954876
What this trial is testing

Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Translational Genomics Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT00109850
What this trial is testing

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Cancer
SWOG Cancer Research Network 22
Testing effectiveness (Phase 2)Study completedNCT00437268
What this trial is testing

Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumor
Eli Lilly and Company 26
Testing effectiveness (Phase 2)Ended earlyNCT04492033
What this trial is testing

CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

Who this might be right for
P1b: Advanced Solid TumorsP2: Biliary Tract Cancer
Handok Inc. 41
Early research (Phase 1)Study completedNCT00132158
What this trial is testing

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
GlioblastomaRhabdomyosarcomasNeuroblastoma+1 more
St. Jude Children's Research Hospital 19
Testing effectiveness (Phase 2)Study completedNCT02558868
What this trial is testing

Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Zhejiang University 80
Early research (Phase 1)Ended earlyNCT00296062
What this trial is testing

Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer

Who this might be right for
Colorectal CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT01963182
What this trial is testing

Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer

Who this might be right for
First Line Metastatic Colorectal Cancer
Centre Jean Perrin 47
Testing effectiveness (Phase 2)Study completedNCT03785873
What this trial is testing

Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
University of Michigan Rogel Cancer Center 34
Early research (Phase 1)Study completedNCT00008424
What this trial is testing

Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 7
Testing effectiveness (Phase 2)Study completedNCT00512681
What this trial is testing

A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms
National Cancer Center, Korea 44
Testing effectiveness (Phase 2)Looking for participantsNCT06801730
What this trial is testing

Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma

Who this might be right for
Glioma
Zhifeng Tian,MD 38
Testing effectiveness (Phase 2)Looking for participantsNCT06438822
What this trial is testing

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
West China Hospital 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07817901
What this trial is testing

Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Combination Therapy With Pembrolizumab and Irinotecan in Patients With Metastatic or Recurrent Malignant Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Yonsei University 46
Testing effectiveness (Phase 2)Study completedNCT02035137
What this trial is testing

131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 114
Next Page